+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

Macular Edema Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Macular Edema Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2023
  • 99 Pages
  • Global
From
Dermatological Drugs Market Report 2024-2034 - Product Thumbnail Image

Dermatological Drugs Market Report 2024-2034

  • Report
  • February 2024
  • 280 Pages
  • Global
From
Graves' Ophthalmopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Graves' Ophthalmopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 67 Pages
  • Global
From
Age Related Macular Degeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Age Related Macular Degeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 289 Pages
  • Global
From
Ophthalmic Pharmaceutical Drugs - Global Strategic Business Report - Product Thumbnail Image

Ophthalmic Pharmaceutical Drugs - Global Strategic Business Report

  • Report
  • October 2025
  • 272 Pages
  • Global
From
Red Biotechnology Market Report and Forecast 2024-2032 - Product Thumbnail Image

Red Biotechnology Market Report and Forecast 2024-2032

  • Report
  • November 2023
  • 172 Pages
  • Global
From
Middle East Respiratory Syndrome (MERS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Middle East Respiratory Syndrome (MERS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 121 Pages
  • Middle East
From
North America Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

North America Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • July 2023
  • 111 Pages
  • North America
From
Europe Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Europe Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • July 2023
  • 119 Pages
  • Europe
From
LAMEA Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

LAMEA Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • July 2023
  • 119 Pages
  • Africa, Middle East
From
Asia Pacific Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Asia Pacific Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • July 2023
  • 119 Pages
  • Asia Pacific
From
Fallopian Tube Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Fallopian Tube Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Colorectal Cancer Drugs Market - Global Forecast 2025-2032 - Product Thumbnail Image

Colorectal Cancer Drugs Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 185 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease (COPD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease (COPD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • January 2023
  • 90 Pages
  • Global
From
Non-Opioid Drugs for Chronic Pain and Pain Management Devices Market, 2018-2025 - Product Thumbnail Image

Non-Opioid Drugs for Chronic Pain and Pain Management Devices Market, 2018-2025

  • Report
  • August 2018
  • 340 Pages
  • Global
From
State of the Biopharmaceutical Industry 2023 - Product Thumbnail Image

State of the Biopharmaceutical Industry 2023

  • Report
  • December 2022
  • 110 Pages
  • Global
From
Immuno-Oncology - Thematic Intelligence - Product Thumbnail Image

Immuno-Oncology - Thematic Intelligence

  • Report
  • May 2023
  • 169 Pages
  • Global
From
Cardiovascular Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Cardiovascular Collaboration and Licensing Deals 2016-2025

  • Report
  • April 2025
  • 300 Pages
  • Global
From
Unresectable Hepatocellular Carcinoma Market Report 2025 - Product Thumbnail Image

Unresectable Hepatocellular Carcinoma Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease (COPD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease (COPD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 541 Pages
  • Global
From
Loading Indicator